85 related articles for article (PubMed ID: 7410539)
1. Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology.
Camanni F; Genazzani AR; Massara F; de Leo V; Molinatti GM; Müller EE
J Clin Endocrinol Metab; 1980 Sep; 51(3):650-3. PubMed ID: 7410539
[No Abstract] [Full Text] [Related]
2. Nomifensine in the diagnosis of hyperprolactinemia.
Gullo D; Carmina E; Mogavero G; Perino A; Venezia R
Acta Eur Fertil; 1981 Dec; 12(4):299-306. PubMed ID: 7342611
[TBL] [Abstract][Full Text] [Related]
3. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
Ferrari C; Crosignani PG; Caldara R; Picciotti MC; Malinverni A; Barattini B; Rampini P; Telloli P
J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
[TBL] [Abstract][Full Text] [Related]
4. Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone tests.
Molinatti GM; Camanni F; Cocchi D; De Leo V; Genazzni AR; Massara F; Muller EE
Panminerva Med; 1981; 23(1):5-10. PubMed ID: 7290727
[No Abstract] [Full Text] [Related]
5. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
[TBL] [Abstract][Full Text] [Related]
6. Nomifensine: diagnostic test in hyperprolactinemic states.
Müller EE; Genazzani AR; Murru S
J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
[TBL] [Abstract][Full Text] [Related]
7. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
[TBL] [Abstract][Full Text] [Related]
8. Some critical considerations on the use of the nomifensine test in the hyperprolactinaemic syndrome.
D'Agata R; Aliffi A; Vicari E; Volpicelli D; Mongioì A; Gulizia S
Horm Res; 1981; 14(3):148-54. PubMed ID: 7286887
[TBL] [Abstract][Full Text] [Related]
9. Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas.
Iannotta F; Fachinetti P; Fachinetti A; Pinotti G; Usellini L
J Endocrinol Invest; 1983 Oct; 6(5):353-8. PubMed ID: 6420458
[TBL] [Abstract][Full Text] [Related]
10. Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.
Minuto F; Barbarino A; Baviera G; Mazzocchi G; De Marinis L; Leonardi R; Bernasconi D; Menini E; Maira G; Anile C
J Endocrinol Invest; 1984 Apr; 7(2):137-40. PubMed ID: 6725869
[TBL] [Abstract][Full Text] [Related]
11. Agreement of prolactin response to cimetidine and nomifensine in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
Iodice M; Lombardi G; Tommaselli A; Rossi R; Annunziato L; Minozzi M
Neuroendocrinology; 1982 Nov; 35(5):333-5. PubMed ID: 7145025
[No Abstract] [Full Text] [Related]
12. A new pharmacological approach to the diagnosis of hyperprolactinaemic states: the nomifensine test.
Genazzani AR; Camanni F; Massara F; Picciolini E; Cocchi D; Belforte L; Müller EE
Acta Endocrinol (Copenh); 1980 Feb; 93(2):139-48. PubMed ID: 6769270
[No Abstract] [Full Text] [Related]
13. Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors.
Crosignani PG; Ferrari C; Malinverni A; Barbieri C; Mattei AM; Caldara R; Rocchetti M
J Clin Endocrinol Metab; 1980 Nov; 51(5):1068-73. PubMed ID: 7419682
[No Abstract] [Full Text] [Related]
14. [Indirect dopamine agonists and direct dopamine antagonists in the diagnosis of hyperprolactinemia].
De Leo V; Massafra C; La Marca S; De Leo M; Venturi C; Urbani TM; Genazzani AR
Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1025-31. PubMed ID: 7138672
[TBL] [Abstract][Full Text] [Related]
15. The effect of nomifensine on prolactin secretion in patients with suspected pituitary microadenoma.
Jeske W; Stopińska U
Endokrynol Pol; 1981; 32(1):17-24. PubMed ID: 7250073
[No Abstract] [Full Text] [Related]
16. Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia.
Dallabonzana D; Spelta B; Botalla L; Oppizzi G; Silvestrini F; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1982 Jun; 54(6):1125-8. PubMed ID: 7076795
[TBL] [Abstract][Full Text] [Related]
17. [Progress in the hormonal detection of pituitary prolactin adenoma].
De Gennes JL; Turpin G; Heshmati HM; Carayon A
Ann Med Interne (Paris); 1982; 133(1):12-6. PubMed ID: 7065584
[No Abstract] [Full Text] [Related]
18. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
Abraham G
Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
[No Abstract] [Full Text] [Related]
19. Nomifensine-induced pregnancy in a hyperprolactinemic woman.
Genazzani AR; De Leo V; Camanni F; Müller EE
J Endocrinol Invest; 1982; 5(2):129-30. PubMed ID: 7096920
[No Abstract] [Full Text] [Related]
20. [Differential diagnosis of hyperprolactinemia].
Takeda R; Minagawa F; Nakabayashi H
Nihon Rinsho; 1986 Mar; 44(3):671-7. PubMed ID: 2874247
[No Abstract] [Full Text] [Related]
[Next] [New Search]